888.435.2220
info@medicure.com
MPH.V
Toggle navigation
Home
Products
Aggrastat (tirofiban HCI)
In Development
Business Development
Generic Products
Tardoxal
News
News Releases
Get News Alerts by Email
Investors
Overview
Corporate Presentation
Corporate Governance
About Us
About Medicure
Management
Board of Directors
Careers
Corporate Compliance
Contact
News Releases
News
News Releases
News Releases
Get News Alerts by Email
Get News Alerts by Email
Year
All Years
2018
2017
2016
2015
2014
2013
2012
2011
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Dec 19, 2017
Medicure Announces FDA Approval Received for Prexxartan®
Dec 14, 2017
Medicure Acquires Exclusive License to Sell and Market Branded Cardiovascular Drug in the U.S.
Nov 21, 2017
Medicure Reports Financial Results for Quarter Ended September 30, 2017
Nov 17, 2017
Medicure Announces Repayment of Outstanding Debt
Nov 15, 2017
Medicure Q3 Results and Conference Call Dates
Show
5
10
25
50
100
per page
«
1
2
3
4
5
6
7
8
9
…
23
»
